BIODESIX INC — Director's Dealing 2023

Jan 6, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2022-11-21

Reporting Person: Kennedy Lawrence T. Jr (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-21	Common Stock	P	8260869	$1.15	Acquired	9148889	Indirect
2022-11-21	Common Stock	P	2608696	$1.15	Acquired	4355914	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166666	Indirect
Common Stock	1155935	Indirect

Footnotes

F1: Reported amounts have been adjusted to reflect the September 27, 2022 transfer of 469,026 shares previously held by the Lair BDSX GRAT 2022-3.2 to the Lawrence T. Kennedy, Jr. Revocable Trust UAD 6/19/01, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Exchange Act.